Skip to main content
logo
Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
32.02
-0.81 (-2.47%)
At close: Jul 15, 2025, 4:00 PM
32.00
-0.02 (-0.06%)
After-hours: Jul 15, 2025, 4:00 PM EDT

Collegium Pharmaceutical Revenue

Collegium Pharmaceutical had revenue of $177.76M in the quarter ending March 31, 2025, with 22.66% growth. This brings the company's revenue in the last twelve months to $664.28M, up 17.17% year-over-year. In the year 2024, Collegium Pharmaceutical had annual revenue of $631.45M with 11.41% growth.

Revenue (ttm)
$664.28M
Revenue Growth
+17.17%
P/S Ratio
1.59
Revenue / Employee
$1,860,737
Employees
357
Market Cap
1.03B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 631.45M 64.68M 11.41%
Dec 31, 2023 566.77M 102.83M 22.17%
Dec 31, 2022 463.93M 187.07M 67.56%
Dec 31, 2021 276.87M -33.15M -10.69%
Dec 31, 2020 310.02M 13.32M 4.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

COLL News

More News